1. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2019. CA Cancer J Clin, 2019. 69(1): p. 7-34.
2. Garnick, M.B. and W.R. Fair, Combating prostate cancer. Sci Am, 1998. 279(6): p. 74-83.
3. Paraskevopoulou, M.D. and A.G. Hatzigeorgiou, Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol, 2016. 1402: p. 271-286.
4. Ma, Y., et al., Membrane-lipid associated lncRNA: A new regulator in cancer signaling. Cancer Lett, 2018. 419: p. 27-29.
5. Srikantan, V., et al., PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A, 2000. 97(22): p. 12216-21.
6. Petrovics, G., et al., Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene, 2004. 23(2): p. 605-11.
7. Romanuik, T.L., et al., LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Med Genomics, 2010. 3: p. 43.
8. Yang, L., et al., lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature, 2013. 500(7464): p. 598-602.
9. Mendell, J.T., MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle, 2005. 4(9): p. 1179-84.
10. Filella, X. and L. Foj, miRNAs as novel biomarkers in the management of prostate cancer. Clin Chem Lab Med, 2017. 55(5): p. 715-736.
11. Liang, T.S., et al., MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2. J Exp Clin Cancer Res, 2019. 38(1): p. 97.
12. Liang, J., N. Liu, and H. Xin, Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506. Gen Physiol Biophys, 2019. 38(4): p. 295-304.
13. Zhang, J., et al., High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival. Ann Transl Med, 2019. 7(14): p. 330.
14. Hao, C.C., et al., TRIAP1 knockdown sensitizes non-small cell lung cancer to ionizing radiation by disrupting redox homeostasis. Thorac Cancer, 2020. 11(4): p. 1015-1025.
15. Cline, M.S., et al., Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser. Sci Rep, 2013. 3.
16. Wang, C., et al., The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma. OncoTargets and Therapy, 2018. 11: p. 5631-5646.
17. Zhang, Q., J. Zheng, and L. Liu, The long noncoding RNA PCGEM1 promotes cell proliferation, migration and invasion via targeting the miR-182/FBXW11 axis in cervical cancer. Cancer Cell Int, 2019. 19: p. 304.
18. Wang, Y., et al., MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6. J Biosci, 2019. 44(6).
19. Luo, J., et al., LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat Commun, 2019. 10(1): p. 2571.
20. de Oliveira, J.C., et al., Long non-coding RNAs in cancer: Another layer of complexity. 2019. 21(1): p. e3065.
21. Anastasiadou, E., L.S. Jacob, and F.J. Slack, Non-coding RNA networks in cancer. Nat Rev Cancer, 2018. 18(1): p. 5-18.
22. Chen, S., et al., LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway. Cell Physiol Biochem, 2018. 47(4): p. 1578-1588.
23. Zhang, J. and H.Y. Jin, Hypoxia-induced LncRNA PCGEM1 promotes invasion and metastasis of gastric cancer through regulating SNAI1. 2019. 21(9): p. 1142-1151.
24. He, J.H., et al., Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer Res, 2014. 33(1): p. 72.
25. Ho, T.T., et al., Regulation of PCGEM1 by p54/nrb in prostate cancer. Sci Rep, 2016. 6: p. 34529.
26. Salmena, L., et al., A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell, 2011. 146(3): p. 353-8.
27. Tutar, Y., Pseudogenes. Comp Funct Genomics, 2012. 2012: p. 424526.
28. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell, 2009. 136(2): p. 215-33.
29. Tutar, Y., miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol, 2014. 15(5): p. 429.
30. Wu, L., Z. Chen, and Y. Xing, MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6. Cell Biol Int, 2018.
31. Jiashi, W., et al., MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression. Aging (Albany NY), 2018. 10(6): p. 1294-1305.
32. Hu, C.Y., et al., MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4. Eur Rev Med Pharmacol Sci, 2019. 23(12): p. 5133-5138.
33. Adams, C., et al., Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance. Oncol Rep, 2015. 34(1): p. 415-22.
34. Yu, T., et al., Upregulation of TRIAP1 by the lncRNA MFI2-AS1/miR-125a-5p Axis Promotes Thyroid Cancer Tumorigenesis. Onco Targets Ther, 2020. 13: p. 6967-6974.
35. Na, C., et al., miR-107 targets TRIAP1 to regulate oral squamous cell carcinoma proliferation and migration. Int J Clin Exp Pathol, 2019. 12(5): p. 1820-1825.
36. Cai, P., et al., MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1. Oncol Lett, 2020. 19(3): p. 1958-1966.